ArticleAnnals of hematology2025

Continous or fixedcarfilzomib, lenalidomide and dexamethasone (krd) for relapsed-refractory multiple myeloma: long-term follow-up from a multicenter, retrospective real-life surveyfrom European myeloma network (emn) Italy.

Concetta Conticello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.